- Home
- RVPH vs TOMZ Comparison
RVPH vs TOMZ Comparison
Compare RVPH & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- TOMZ
- Stock Information
- Founded
- RVPH 2006
- TOMZ 1979
- Country
- RVPH United States
- TOMZ United States
- Employees
- RVPH N/A
- TOMZ N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- RVPH Health Care
- TOMZ Finance
- Exchange
- RVPH Nasdaq
- TOMZ Nasdaq
- Market Cap
- RVPH 18.1M
- TOMZ 17.5M
- IPO Year
- RVPH N/A
- TOMZ N/A
- Fundamental
- Price
- RVPH $0.54
- TOMZ $0.83
- Analyst Decision
- RVPH Strong Buy
- TOMZ Strong Buy
- Analyst Count
- RVPH 6
- TOMZ 1
- Target Price
- RVPH $3.33
- TOMZ $3.50
- AVG Volume (30 Days)
- RVPH 7.9M
- TOMZ 30.3K
- Earning Date
- RVPH 11-13-2025
- TOMZ 11-14-2025
- Dividend Yield
- RVPH N/A
- TOMZ N/A
- EPS Growth
- RVPH N/A
- TOMZ N/A
- EPS
- RVPH N/A
- TOMZ N/A
- Revenue
- RVPH N/A
- TOMZ $6,219,036.00
- Revenue This Year
- RVPH N/A
- TOMZ $18.31
- Revenue Next Year
- RVPH N/A
- TOMZ $103.30
- P/E Ratio
- RVPH N/A
- TOMZ N/A
- Revenue Growth
- RVPH N/A
- TOMZ N/A
- 52 Week Low
- RVPH $0.25
- TOMZ $0.63
- 52 Week High
- RVPH $4.28
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- RVPH 48.43
- TOMZ 33.95
- Support Level
- RVPH $0.45
- TOMZ $0.88
- Resistance Level
- RVPH $0.59
- TOMZ $0.95
- Average True Range (ATR)
- RVPH 0.06
- TOMZ 0.06
- MACD
- RVPH -0.01
- TOMZ -0.01
- Stochastic Oscillator
- RVPH 41.93
- TOMZ 0.42
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.